A
$ Value
$0
Shares
22,839
Price
$0
Filed
Nov 14
Insider
Name
Friscia Stephen
Title
—
CIK
0002028845
Roles
Director
Transaction Details
Transaction Date
2025-11-14
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
25,000
Footnotes
Represents a grant of Restricted Stock Units ("RSUs"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the "Plan Amendment"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance.
Filing Info
Friscia Stephen's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-13 | QCLS | A | $0 |
| 2025-11-14 | QCLS | A | $0 |
| 2025-10-03 | QCLS | A | $0 |
Other Insiders at QCLS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Silverman Joshua
Executive Chairman
|
— | — | 2026-04-13 |
| White Billy Joe | — | — | 2026-04-13 |
| Bernstein Bruce | — | — | 2026-04-13 |
|
Glass Mitchell
Chief Medical Officer
|
— | — | 2026-04-13 |
| Friscia Stephen | — | — | 2026-04-13 |
| Voss Chelsea Sierra | — | — | 2026-04-13 |